Application 078902
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 10MG BASE | No | No |
| 002 | PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 20MG BASE | No | No |
| 003 | PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 30MG BASE | No | No |
| 004 | PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 40MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078902-001 | PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2008-03-13 | |
| A078902-002 | PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2008-03-13 | |
| A078902-003 | PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2008-03-13 | |
| A078902-004 | PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2008-03-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078902-001 | AB |
| A078902-002 | AB |
| A078902-003 | AB |
| A078902-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A078902-001 | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2008-03-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078902-002 | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2008-03-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078902-003 | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2008-03-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078902-004 | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2008-03-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078902-001 | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2008-03-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078902-002 | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2008-03-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078902-003 | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2008-03-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078902-004 | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2008-03-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078902-001 | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2008-03-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078902-002 | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2008-03-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078902-003 | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2008-03-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078902-004 | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2008-03-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078902-001 | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2008-03-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078902-002 | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2008-03-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078902-003 | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2008-03-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078902-004 | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2008-03-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078902-001 | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2008-03-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078902-002 | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2008-03-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078902-003 | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2008-03-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078902-004 | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2008-03-13 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078902-001 | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2008-03-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078902-002 | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2008-03-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078902-003 | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2008-03-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078902-004 | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2008-03-13 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078902-001 | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2008-03-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078902-002 | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2008-03-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078902-003 | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2008-03-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078902-004 | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2008-03-13 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078902-001 | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2008-03-13 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078902-002 | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2008-03-13 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078902-003 | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2008-03-13 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078902-004 | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2008-03-13 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078902-001 | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2008-03-13 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078902-002 | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2008-03-13 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078902-003 | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2008-03-13 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078902-004 | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2008-03-13 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078902-001 | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2008-03-13 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078902-002 | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2008-03-13 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078902-003 | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2008-03-13 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078902-004 | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2008-03-13 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A078902-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078902-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078902-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078902-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078902-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078902-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078902-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078902-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A078902-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078902-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078902-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078902-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078902-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078902-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078902-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078902-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078902-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078902-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078902-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078902-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078902-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078902-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078902-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078902-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078902-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078902-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078902-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078902-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078902-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078902-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078902-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078902-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078902-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078902-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078902-003 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078902-004 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A078902-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078902-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078902-003 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078902-004 | AB | 1 | d06236e962d9… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Paroxetine | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | PD-Rx Pharmaceuticals, Inc. | 619e10bb-6e5d-4ec3-a85a-6270965f5389 | 2026-06-11 | Boxed warning, Warnings, Adverse reactions | 078902 ANDA078902 55289-053 |
| Paroxetine | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | PD-Rx Pharmaceuticals, Inc. | ff7c7e20-c9ee-4693-beaa-7ac532d5c4b7 | 2026-06-11 | Boxed warning, Warnings, Adverse reactions | 078902 ANDA078902 55289-037 |
| Paroxetine | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | Mylan Pharmaceuticals Inc. | 89dd7e24-85fc-4152-89ea-47ec2b48a1ed | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | 078902 ANDA078902 0378-7003 0378-7002 0378-7004 0378-7001 |
| Paroxetine | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | Preferred Pharmaceuticals Inc. | 2b2e6cd0-d779-4b7b-b3aa-85b796874ac3 | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | 078902 ANDA078902 |
| Paroxetine | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | Aphena Pharma Solutions - Tennessee, LLC | ec9622ca-1f56-4216-9445-485791c4c0ed | 2020-07-16 | Boxed warning, Warnings, Adverse reactions | 078902 ANDA078902 43353-544 43353-554 |
| Paroxetine | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | Aphena Pharma Solutions - Tennessee, LLC | 45ef7ce8-5aa0-488c-a81c-cdfbda66ac04 | 2019-02-27 | Boxed warning, Warnings, Adverse reactions | 078902 ANDA078902 71610-243 |
| Paroxetine | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | Aphena Pharma Solutions - Tennessee, LLC | 2eebd2b6-7c64-45ca-8eb5-5201137f610a | 2018-12-18 | Boxed warning, Warnings, Adverse reactions | 078902 ANDA078902 71610-204 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-7001 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7001 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7001 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7001 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7002 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7002 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7002 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7002 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7003 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7003 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7003 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7003 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7004 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7004 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7004 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7004 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 43063-170 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43353-544 | Paroxetine | paroxetine hydrochloride hemihydrate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-544 | Paroxetine | paroxetine hydrochloride hemihydrate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-544 | Paroxetine | paroxetine hydrochloride hemihydrate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-554 | Paroxetine | paroxetine hydrochloride hemihydrate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-554 | Paroxetine | paroxetine hydrochloride hemihydrate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-554 | Paroxetine | paroxetine hydrochloride hemihydrate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 51079-774 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Institutional Inc. | ANDA | Current |
| 51079-774 | Paroxetine | paroxetine hydrochloride hemihydrate | Mylan Institutional Inc. | ANDA | Current |
| 53808-0393 | Paroxetine | Paroxetine hydrochloride hemihydrate | State of Florida DOH Central Pharmacy | ANDA | Current |
| 53808-0394 | Paroxetine | Paroxetine hydrochloride hemihydrate | State of Florida DOH Central Pharmacy | ANDA | Current |
| 53808-0601 | Paroxetine | Paroxetine hydrochloride hemihydrate | State of Florida DOH Central Pharmacy | ANDA | Current |
| 53808-0655 | Paroxetine | Paroxetine hydrochloride hemihydrate | State of Florida DOH Central Pharmacy | ANDA | Current |
| 55154-5087 | Paroxetine | Paroxetine hydrochloride hemihydrate | Cardinal Health | ANDA | Current |
| 55154-5087 | Paroxetine | Paroxetine hydrochloride hemihydrate | Cardinal Health | ANDA | Current |
| 55289-037 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-037 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-037 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-037 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-037 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-037 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-053 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-053 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-053 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-053 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-053 | Paroxetine | paroxetine hydrochloride hemihydrate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 58517-160 | paroxetine hydrochloride | paroxetine hydrochloride | New Horizon Rx Group, LLC | ANDA | Current |
| 70518-1658 | Paroxetine | paroxetine hydrochloride hemihydrate | REMEDYREPACK INC. | ANDA | Current |
| 70518-1658 | Paroxetine | paroxetine hydrochloride hemihydrate | REMEDYREPACK INC. | ANDA | Current |
| 71610-204 | Paroxetine | paroxetine hydrochloride hemihydrate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 71610-243 | Paroxetine | paroxetine hydrochloride hemihydrate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 44397 | ORIG | 2008-03-21 |